The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Montelukast Sodium Market Research Report 2024

Global Montelukast Sodium Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1410937

No of Pages : 120

Synopsis
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The global Montelukast Sodium market was valued at US$ 343.8 million in 2023 and is anticipated to reach US$ 816.7 million by 2030, witnessing a CAGR of 13.0% during the forecast period 2024-2030.
The global montelukast sodium sale market was led by USA, India, Europe and China, where the USA and India are important sales market. At present, there are some manufacturers in every region and the major manufacturers’ activities of montelukast sodium are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, etc. Morepen Laboratories is the globe sales leader, holding 22% sales share in global.
This report aims to provide a comprehensive presentation of the global market for Montelukast Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Montelukast Sodium.
Report Scope
The Montelukast Sodium market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Montelukast Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Montelukast Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Segment by Type
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Segment by Application
Tablets
Chewable Tablet
Oral Solution
Production by Region
North America
Europe
Southeast Asia
Japan
China
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Montelukast Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Montelukast Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Montelukast Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index
1 Montelukast Sodium Market Overview
1.1 Product Definition
1.2 Montelukast Sodium Segment by Type
1.2.1 Global Montelukast Sodium Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Montelukast Sodium Amorphous
1.2.3 Montelukast Sodium Crystalline
1.3 Montelukast Sodium Segment by Application
1.3.1 Global Montelukast Sodium Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Tablets
1.3.3 Chewable Tablet
1.3.4 Oral Solution
1.4 Global Market Growth Prospects
1.4.1 Global Montelukast Sodium Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Montelukast Sodium Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Montelukast Sodium Production Estimates and Forecasts (2019-2030)
1.4.4 Global Montelukast Sodium Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Montelukast Sodium Production Market Share by Manufacturers (2019-2024)
2.2 Global Montelukast Sodium Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Montelukast Sodium, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Montelukast Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Montelukast Sodium Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Montelukast Sodium, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Montelukast Sodium, Product Offered and Application
2.8 Global Key Manufacturers of Montelukast Sodium, Date of Enter into This Industry
2.9 Montelukast Sodium Market Competitive Situation and Trends
2.9.1 Montelukast Sodium Market Concentration Rate
2.9.2 Global 5 and 10 Largest Montelukast Sodium Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Montelukast Sodium Production by Region
3.1 Global Montelukast Sodium Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Montelukast Sodium Production Value by Region (2019-2030)
3.2.1 Global Montelukast Sodium Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Montelukast Sodium by Region (2025-2030)
3.3 Global Montelukast Sodium Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Montelukast Sodium Production by Region (2019-2030)
3.4.1 Global Montelukast Sodium Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Montelukast Sodium by Region (2025-2030)
3.5 Global Montelukast Sodium Market Price Analysis by Region (2019-2024)
3.6 Global Montelukast Sodium Production and Value, Year-over-Year Growth
3.6.1 North America Montelukast Sodium Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Montelukast Sodium Production Value Estimates and Forecasts (2019-2030)
3.6.3 Southeast Asia Montelukast Sodium Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Montelukast Sodium Production Value Estimates and Forecasts (2019-2030)
3.6.5 China Montelukast Sodium Production Value Estimates and Forecasts (2019-2030)
3.6.6 India Montelukast Sodium Production Value Estimates and Forecasts (2019-2030)
4 Montelukast Sodium Consumption by Region
4.1 Global Montelukast Sodium Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Montelukast Sodium Consumption by Region (2019-2030)
4.2.1 Global Montelukast Sodium Consumption by Region (2019-2024)
4.2.2 Global Montelukast Sodium Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Montelukast Sodium Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Montelukast Sodium Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Montelukast Sodium Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Montelukast Sodium Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Montelukast Sodium Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Montelukast Sodium Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Montelukast Sodium Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Montelukast Sodium Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Montelukast Sodium Production by Type (2019-2030)
5.1.1 Global Montelukast Sodium Production by Type (2019-2024)
5.1.2 Global Montelukast Sodium Production by Type (2025-2030)
5.1.3 Global Montelukast Sodium Production Market Share by Type (2019-2030)
5.2 Global Montelukast Sodium Production Value by Type (2019-2030)
5.2.1 Global Montelukast Sodium Production Value by Type (2019-2024)
5.2.2 Global Montelukast Sodium Production Value by Type (2025-2030)
5.2.3 Global Montelukast Sodium Production Value Market Share by Type (2019-2030)
5.3 Global Montelukast Sodium Price by Type (2019-2030)
6 Segment by Application
6.1 Global Montelukast Sodium Production by Application (2019-2030)
6.1.1 Global Montelukast Sodium Production by Application (2019-2024)
6.1.2 Global Montelukast Sodium Production by Application (2025-2030)
6.1.3 Global Montelukast Sodium Production Market Share by Application (2019-2030)
6.2 Global Montelukast Sodium Production Value by Application (2019-2030)
6.2.1 Global Montelukast Sodium Production Value by Application (2019-2024)
6.2.2 Global Montelukast Sodium Production Value by Application (2025-2030)
6.2.3 Global Montelukast Sodium Production Value Market Share by Application (2019-2030)
6.3 Global Montelukast Sodium Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Morepen Laboratories
7.1.1 Morepen Laboratories Montelukast Sodium Corporation Information
7.1.2 Morepen Laboratories Montelukast Sodium Product Portfolio
7.1.3 Morepen Laboratories Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Morepen Laboratories Main Business and Markets Served
7.1.5 Morepen Laboratories Recent Developments/Updates
7.2 Mylan
7.2.1 Mylan Montelukast Sodium Corporation Information
7.2.2 Mylan Montelukast Sodium Product Portfolio
7.2.3 Mylan Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Mylan Main Business and Markets Served
7.2.5 Mylan Recent Developments/Updates
7.3 TAPI
7.3.1 TAPI Montelukast Sodium Corporation Information
7.3.2 TAPI Montelukast Sodium Product Portfolio
7.3.3 TAPI Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.3.4 TAPI Main Business and Markets Served
7.3.5 TAPI Recent Developments/Updates
7.4 MSN Laboratories
7.4.1 MSN Laboratories Montelukast Sodium Corporation Information
7.4.2 MSN Laboratories Montelukast Sodium Product Portfolio
7.4.3 MSN Laboratories Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.4.4 MSN Laboratories Main Business and Markets Served
7.4.5 MSN Laboratories Recent Developments/Updates
7.5 Ultratech India
7.5.1 Ultratech India Montelukast Sodium Corporation Information
7.5.2 Ultratech India Montelukast Sodium Product Portfolio
7.5.3 Ultratech India Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Ultratech India Main Business and Markets Served
7.5.5 Ultratech India Recent Developments/Updates
7.6 Aurobindo Pharma
7.6.1 Aurobindo Pharma Montelukast Sodium Corporation Information
7.6.2 Aurobindo Pharma Montelukast Sodium Product Portfolio
7.6.3 Aurobindo Pharma Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Aurobindo Pharma Main Business and Markets Served
7.6.5 Aurobindo Pharma Recent Developments/Updates
7.7 Hetero Labs
7.7.1 Hetero Labs Montelukast Sodium Corporation Information
7.7.2 Hetero Labs Montelukast Sodium Product Portfolio
7.7.3 Hetero Labs Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Hetero Labs Main Business and Markets Served
7.7.5 Hetero Labs Recent Developments/Updates
7.8 Unimark Remedies
7.8.1 Unimark Remedies Montelukast Sodium Corporation Information
7.8.2 Unimark Remedies Montelukast Sodium Product Portfolio
7.8.3 Unimark Remedies Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Unimark Remedies Main Business and Markets Served
7.7.5 Unimark Remedies Recent Developments/Updates
7.9 Jubilant Cadista
7.9.1 Jubilant Cadista Montelukast Sodium Corporation Information
7.9.2 Jubilant Cadista Montelukast Sodium Product Portfolio
7.9.3 Jubilant Cadista Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Jubilant Cadista Main Business and Markets Served
7.9.5 Jubilant Cadista Recent Developments/Updates
7.10 Aamorb Pharmaceuticals
7.10.1 Aamorb Pharmaceuticals Montelukast Sodium Corporation Information
7.10.2 Aamorb Pharmaceuticals Montelukast Sodium Product Portfolio
7.10.3 Aamorb Pharmaceuticals Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Aamorb Pharmaceuticals Main Business and Markets Served
7.10.5 Aamorb Pharmaceuticals Recent Developments/Updates
7.11 Sudarshan Group
7.11.1 Sudarshan Group Montelukast Sodium Corporation Information
7.11.2 Sudarshan Group Montelukast Sodium Product Portfolio
7.11.3 Sudarshan Group Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Sudarshan Group Main Business and Markets Served
7.11.5 Sudarshan Group Recent Developments/Updates
7.12 Ortin Laboratories
7.12.1 Ortin Laboratories Montelukast Sodium Corporation Information
7.12.2 Ortin Laboratories Montelukast Sodium Product Portfolio
7.12.3 Ortin Laboratories Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Ortin Laboratories Main Business and Markets Served
7.12.5 Ortin Laboratories Recent Developments/Updates
7.13 Vamsi Labs
7.13.1 Vamsi Labs Montelukast Sodium Corporation Information
7.13.2 Vamsi Labs Montelukast Sodium Product Portfolio
7.13.3 Vamsi Labs Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Vamsi Labs Main Business and Markets Served
7.13.5 Vamsi Labs Recent Developments/Updates
7.14 Adley Group
7.14.1 Adley Group Montelukast Sodium Corporation Information
7.14.2 Adley Group Montelukast Sodium Product Portfolio
7.14.3 Adley Group Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Adley Group Main Business and Markets Served
7.14.5 Adley Group Recent Developments/Updates
7.15 Medopharm
7.15.1 Medopharm Montelukast Sodium Corporation Information
7.15.2 Medopharm Montelukast Sodium Product Portfolio
7.15.3 Medopharm Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Medopharm Main Business and Markets Served
7.15.5 Medopharm Recent Developments/Updates
7.16 Hengyuan Pharmaceutical
7.16.1 Hengyuan Pharmaceutical Montelukast Sodium Corporation Information
7.16.2 Hengyuan Pharmaceutical Montelukast Sodium Product Portfolio
7.16.3 Hengyuan Pharmaceutical Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Hengyuan Pharmaceutical Main Business and Markets Served
7.16.5 Hengyuan Pharmaceutical Recent Developments/Updates
7.17 Arromax Pharmaceutical Technology
7.17.1 Arromax Pharmaceutical Technology Montelukast Sodium Corporation Information
7.17.2 Arromax Pharmaceutical Technology Montelukast Sodium Product Portfolio
7.17.3 Arromax Pharmaceutical Technology Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Arromax Pharmaceutical Technology Main Business and Markets Served
7.17.5 Arromax Pharmaceutical Technology Recent Developments/Updates
7.18 Lihe Wuhan New Chemical Materials
7.18.1 Lihe Wuhan New Chemical Materials Montelukast Sodium Corporation Information
7.18.2 Lihe Wuhan New Chemical Materials Montelukast Sodium Product Portfolio
7.18.3 Lihe Wuhan New Chemical Materials Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.18.4 Lihe Wuhan New Chemical Materials Main Business and Markets Served
7.18.5 Lihe Wuhan New Chemical Materials Recent Developments/Updates
7.19 Shanghai Huachu Chemical
7.19.1 Shanghai Huachu Chemical Montelukast Sodium Corporation Information
7.19.2 Shanghai Huachu Chemical Montelukast Sodium Product Portfolio
7.19.3 Shanghai Huachu Chemical Montelukast Sodium Production, Value, Price and Gross Margin (2019-2024)
7.19.4 Shanghai Huachu Chemical Main Business and Markets Served
7.19.5 Shanghai Huachu Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Montelukast Sodium Industry Chain Analysis
8.2 Montelukast Sodium Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Montelukast Sodium Production Mode & Process
8.4 Montelukast Sodium Sales and Marketing
8.4.1 Montelukast Sodium Sales Channels
8.4.2 Montelukast Sodium Distributors
8.5 Montelukast Sodium Customers
9 Montelukast Sodium Market Dynamics
9.1 Montelukast Sodium Industry Trends
9.2 Montelukast Sodium Market Drivers
9.3 Montelukast Sodium Market Challenges
9.4 Montelukast Sodium Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’